Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gynecologic 1

Conditions

Ovarian Neoplasms 370Endometrial Neoplasms 213Uterine Cervical Neoplasms 194Breast Neoplasms 111Fallopian Tube Neoplasms 100Colorectal Neoplasms 85Carcinoma, Non-Small-Cell Lung 76Neoplasms 66Pancreatic Neoplasms 61Stomach Neoplasms 55Prostatic Neoplasms 52Neoplasm Metastasis 52Lung Neoplasms 47Melanoma 44Carcinoma, Ovarian Epithelial 43Triple Negative Breast Neoplasms 39Squamous Cell Carcinoma of Head and Neck 36Esophageal Neoplasms 35Carcinoma, Renal Cell 35Colonic Neoplasms 31Urinary Bladder Neoplasms 30Head and Neck Neoplasms 30Peritoneal Neoplasms 29Uterine Neoplasms 28Carcinoma, Hepatocellular 27Vulvar Neoplasms 26Carcinoma, Transitional Cell 25Small Cell Lung Carcinoma 23Sarcoma 20Rectal Neoplasms 19

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperplasia × Gynecologic × 90 days × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡